Back to Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   Abstract views HTML views PDF downloads Totals
12,945 Dovepress* 7,778 499+ 4,352 8,277
PubMed Central* 15 4,653 1,384 4,668
Totals 7,793 5,152 5,736 12,945
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar